{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:53:35Z","timestamp":1760576015883,"version":"build-2065373602"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.clon.2012.02.008","type":"journal-article","created":{"date-parts":[[2012,3,17]],"date-time":"2012-03-17T14:46:12Z","timestamp":1331995572000},"page":"313-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Radiotherapy Studies and Extra-nodal Non-Hodgkin Lymphomas, Progress and Challenges"],"prefix":"10.1016","volume":"24","author":[{"given":"L.","family":"Specht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2012.02.008_bib1","first-page":"1860","article-title":"Report of the Committee on Hodgkin's Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1016\/j.clon.2012.02.008_bib2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0277-5379(91)90081-N","article-title":"Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group","volume":"27","author":"D'Amore","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2012.02.008_bib3","series-title":"Non-Hodgkin lymphomas","first-page":"540","article-title":"Unique aspects of primary extranodal lymphomas","author":"Gospodarowicz","year":"2010"},{"key":"10.1016\/j.clon.2012.02.008_bib4","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clon.2012.02.008_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1023\/A:1008282818705","article-title":"Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas","volume":"8","author":"Zucca","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1023\/A:1008313229892","article-title":"Primary extranodal non-Hodgkin's lymphomas. Part 2: head and neck, central nervous system and other less common sites","volume":"10","author":"Zucca","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.sla.0000129354.31318.f1","article-title":"The role of surgery in primary gastric lymphoma: results of a controlled clinical trial","volume":"240","author":"Aviles","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.clon.2012.02.008_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1385\/MO:22:1:057","article-title":"Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial","volume":"22","author":"Aviles","year":"2005","journal-title":"Med Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1385\/MO:23:2:295","article-title":"Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma","volume":"23","author":"Aviles","year":"2006","journal-title":"Med Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1055\/s-0029-1246012","article-title":"Outcome and quality of life favour a conservative treatment of patients with primary gastric lymphoma","volume":"49","author":"Fischbach","year":"2011","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.clon.2012.02.008_bib11","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1002\/1097-0142(19900601)65:11<2528::AID-CNCR2820651123>3.0.CO;2-W","article-title":"The role of surgery in the multimodal treatment of primary gastric non-Hodgkin's lymphomas. A report of 76 cases and review of the literature","volume":"65","author":"Gobbi","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2012.02.008_bib12","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1200\/JCO.2001.19.18.3874","article-title":"Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma \u2013 results of the prospective German Multicenter Study GIT NHL 01\/92","volume":"19","author":"Koch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib13","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1200\/JCO.2005.04.031","article-title":"Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02\/96)","volume":"23","author":"Koch","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1200\/JCO.1990.8.2.266","article-title":"Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma","volume":"8","author":"Maor","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib15","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","article-title":"Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy","volume":"116","author":"Goda","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2012.02.008_bib16","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1200\/JCO.1998.16.5.1916","article-title":"Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone","volume":"16","author":"Schechter","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.radonc.2008.02.012","article-title":"Long-term results of stomach-conserving therapy in gastric MALT lymphoma","volume":"87","author":"Vrieling","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0360-3016(99)00522-2","article-title":"Low-grade MALT lymphoma of the stomach: a review of treatment options","volume":"46","author":"Schechter","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.008_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12032-009-9207-y","article-title":"Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis","volume":"27","author":"Zullo","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2141.2006.06444.x","article-title":"Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?","volume":"136","author":"Ferrucci","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clon.2012.02.008_bib21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/10428190902912478","article-title":"Early stage gastric diffuse large B-cell lymphomas: results of a randomized trial comparing chemotherapy alone versus chemotherapy\u00a0+\u00a0involved field radiotherapy. (IELSG 4). [corrected]","volume":"50","author":"Martinelli","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clon.2012.02.008_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/978-3-642-57054-4_14","article-title":"Primary gastric lymphoma: brief overview of the recent Princess Margaret Hospital experience","volume":"156","author":"Gospodarowicz","year":"2000","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.clon.2012.02.008_bib23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1349-7006.2005.00051.x","article-title":"Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II, diffuse large B-cell lymphoma of the stomach","volume":"96","author":"Ishikura","year":"2005","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clon.2012.02.008_bib24","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1080\/10428190600556239","article-title":"CHOP followed by involved field radiotherapy for localized primary gastric diffuse large B-cell lymphoma: results of a multi center phase II study and quality of life evaluation","volume":"47","author":"Park","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clon.2012.02.008_bib25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ijrobp.2009.01.061","article-title":"Accuracy of ultrasound-based image guidance for daily positioning of the upper abdomen: an online comparison with cone beam CT","volume":"74","author":"Boda-Heggemann","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.008_bib26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ijrobp.2004.10.025","article-title":"Radiation treatment planning techniques for lymphoma of the stomach","volume":"62","author":"Della Biancia","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.008_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10147-005-0557-y","article-title":"A case of gastric lymphoma with marked interfractional gastric movement during radiation therapy","volume":"11","author":"Isobe","year":"2006","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib28","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"Tsang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.radonc.2007.12.018","article-title":"Intrafractional gastric motion and interfractional stomach deformity during radiation therapy","volume":"87","author":"Watanabe","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1440-1673.1999.00600.x","article-title":"Gastric irradiation for MALT lymphoma: reducing the target volume, fast!","volume":"43","author":"Wirth","year":"1999","journal-title":"Australas Radiol"},{"key":"10.1016\/j.clon.2012.02.008_bib31","first-page":"308","article-title":"Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma","volume":"18","author":"Funk","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clon.2012.02.008_bib32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1396-0296.2003.01647.x","article-title":"Mycosis fungoides: radiation therapy","volume":"16","author":"Hoppe","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clon.2012.02.008_bib33","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0889-8588(03)00108-4","article-title":"Total skin electron beam radiotherapy for patients who have mycosis fungoides","volume":"17","author":"Jones","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.clon.2012.02.008_bib34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1067\/mjd.2002.123482","article-title":"Total skin electron radiation in the management of mycosis fungoides: consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group","volume":"47","author":"Jones","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clon.2012.02.008_bib35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archdermatol.2011.98","article-title":"The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides","volume":"147","author":"Navi","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clon.2012.02.008_bib36","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.ijrobp.2003.08.007","article-title":"Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation)","volume":"58","author":"Ysebaert","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.008_bib37","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJM198912283212603","article-title":"A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides","volume":"321","author":"Kaye","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2012.02.008_bib38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/COC.0b013e3181841f5c","article-title":"Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma\/mycosis fungoides: a pilot study","volume":"32","author":"Yu","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib39","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1016\/j.ijrobp.2011.01.023","article-title":"Revisiting low-dose total skin electron beam therapy in mycosis fungoides","volume":"81","author":"Harrison","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.008_bib40","first-page":"399","article-title":"Low-dose total skin electron beam therapy as a debulking agent for cutaneous t-cell lymphoma: an open-label prospective phase II study","volume":"166","author":"Kamstrup","year":"2012","journal-title":"Br\u00a0J\u00a0Dermatol"},{"key":"10.1016\/j.clon.2012.02.008_bib41","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ijrobp.2007.11.039","article-title":"A\u00a0prospective, open-label study of low-dose total skin electron beam therapy in mycosis fungoides","volume":"71","author":"Kamstrup","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.008_bib42","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clon.2012.02.008_bib43","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(03)02484-8","article-title":"CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma","volume":"49","author":"Liu","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clon.2012.02.008_bib44","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.ijrobp.2007.08.077","article-title":"Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy","volume":"70","author":"Yu","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.008_bib45","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0360-3016(02)04199-8","article-title":"Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma","volume":"55","author":"Eich","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.008_bib46","first-page":"49","article-title":"Dermatologic radiotherapy of primary cutaneous follicle center cell lymphoma","volume":"13","author":"Piccinno","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clon.2012.02.008_bib47","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib48","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","article-title":"Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification","volume":"143","author":"Senff","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clon.2012.02.008_bib49","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clon.2012.02.008_bib50","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib51","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","article-title":"Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study","volume":"19","author":"Grange","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib52","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archderm.1996.03890350042008","article-title":"Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group","volume":"132","author":"Vermeer","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clon.2012.02.008_bib53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0964-1955(95)00058-5","article-title":"Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: radiotherapy versus chemotherapy versus combined therapy","volume":"32B","author":"Aviles","year":"1996","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/COC.0b013e318187ddbb","article-title":"Long-term outcomes for stage I\u2013II aggressive non-Hodgkin lymphoma of Waldeyer's ring","volume":"32","author":"Chang","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib55","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/hed.1077","article-title":"Localized non-Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients","volume":"23","author":"Ezzat","year":"2001","journal-title":"Head Neck"},{"key":"10.1016\/j.clon.2012.02.008_bib56","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1080\/10428190802493686","article-title":"Non-Hodgkin lymphoma of the Waldeyer's ring: clinicopathologic and therapeutic issues","volume":"49","author":"Laskar","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clon.2012.02.008_bib57","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hon.2900050309","article-title":"Management of stage I\u2013II diffuse aggressive non-Hodgkin's lymphoma of the Waldeyer's ring: combined modality therapy versus radiotherapy alone","volume":"5","author":"Liang","year":"1987","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib58","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/1097-0142(19871001)60:7<1505::AID-CNCR2820600717>3.0.CO;2-K","article-title":"Radiotherapy versus radiotherapy plus chemotherapy in stages I and II non-Hodgkin's lymphoma of the upper digestive and respiratory tract","volume":"60","author":"Ossenkoppele","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2012.02.008_bib59","first-page":"2837","article-title":"Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN)","volume":"17","author":"Pasini","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clon.2012.02.008_bib60","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3109\/02841869309092451","article-title":"Stage IA non-Hodgkin's lymphoma of the Waldeyer's ring. Limited chemotherapy and radiation therapy versus radiation therapy alone","volume":"32","author":"Uematsu","year":"1993","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2007.05.073","article-title":"Early or up-front radiotherapy improved survival of localized extranodal NK\/T-cell lymphoma, nasal-type in the upper aerodigestive tract","volume":"70","author":"Huang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.008_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jjco\/hyi006","article-title":"Treatment outcome of angiocentric T-cell and NK\/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy","volume":"35","author":"Kim","year":"2005","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib63","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","article-title":"Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma","volume":"24","author":"Li","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib64","unstructured":"Li YX, Wang H, Jin J, et\u00a0al. Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK\/T-cell lymphoma. Int J Radiat Oncol Biol Phys (in press)."},{"key":"10.1016\/j.clon.2012.02.008_bib65","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2009-07-235853","article-title":"Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK\/T-cell lymphoma in children and adolescents","volume":"114","author":"Wang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clon.2012.02.008_bib66","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/annonc\/mdh143","article-title":"Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)\/T-cell lymphoma: a single institute survey in Taiwan","volume":"15","author":"You","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib67","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/cncr.21656","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters","volume":"106","author":"Isobe","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2012.02.008_bib68","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-cell lymphoma: consortium for Improving Survival of Lymphoma study","volume":"27","author":"Kim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib69","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","article-title":"Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211","volume":"27","author":"Yamaguchi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib70","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1259\/bjr\/83758373","article-title":"A comparison of radiation treatment plans using IMRT with helical tomotherapy and 3D conformal radiotherapy for nasal natural killer\/T-cell lymphoma","volume":"82","author":"Tomita","year":"2009","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clon.2012.02.008_bib71","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/10428190600565651","article-title":"Treatment outcome of front-line systemic chemotherapy for localized extranodal NK\/T cell lymphoma in nasal and upper aerodigestive tract","volume":"47","author":"Kim","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clon.2012.02.008_bib72","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.radonc.2009.08.045","article-title":"A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE\/IIE extranodal NK\/T-cell lymphoma, nasal type in the upper aerodigestive tract","volume":"93","author":"Ma","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib73","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10428190601059795","article-title":"Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity","volume":"48","author":"Wang","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clon.2012.02.008_bib74","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)02916-4","article-title":"Early stage nasal NK\/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality","volume":"54","author":"Cheung","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.008_bib75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0167-8140(01)00428-5","article-title":"Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck","volume":"61","author":"Kim","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib76","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/1097-0142(197410)34:4<1293::AID-CNCR2820340441>3.0.CO;2-P","article-title":"Primary malignant lymphomas of the central nervous system","volume":"34","author":"Henry","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2012.02.008_bib77","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1200\/JCO.1985.3.4.490","article-title":"Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival","volume":"3","author":"Loeffler","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib78","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0360-3016(92)90538-S","article-title":"Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315","volume":"23","author":"Nelson","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.008_bib79","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S1470-2045(10)70229-1","article-title":"High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial","volume":"11","author":"Thiel","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib80","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/cncr.23670","article-title":"Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy","volume":"113","author":"Ekenel","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2012.02.008_bib81","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1212\/WNL.58.10.1513","article-title":"A multicenter study of treatment of primary CNS lymphoma","volume":"58","author":"Ferreri","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.clon.2012.02.008_bib82","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1200\/JCO.2006.06.6910","article-title":"Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma","volume":"24","author":"Gavrilovic","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib83","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1212\/WNL.62.4.544","article-title":"Cognitive status and quality of life after treatment for primary CNS lymphoma","volume":"62","author":"Harder","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.clon.2012.02.008_bib84","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1200\/JCO.2003.04.056","article-title":"Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy","volume":"21","author":"Pels","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib85","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11060-008-9716-0","article-title":"Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy","volume":"91","author":"Correa","year":"2009","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.clon.2012.02.008_bib86","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2010.01.066","article-title":"Consolidation radiotherapy in primary central nervous system lymphomas: impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapy","volume":"80","author":"Ferreri","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.008_bib87","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2007.12.5062","article-title":"Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma","volume":"25","author":"Shah","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2012.02.008_bib88","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.meddos.2007.12.004","article-title":"Stereotactic radiotherapy for unilateral orbital lymphoma and orbital pseudo-tumors: a planning study","volume":"34","author":"Chino","year":"2009","journal-title":"Med Dosim"},{"key":"10.1016\/j.clon.2012.02.008_bib89","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11604-008-0276-1","article-title":"Intensity-modulated radiation therapy for orbital lymphoma","volume":"26","author":"Goyal","year":"2008","journal-title":"Radiat Med"},{"key":"10.1016\/j.clon.2012.02.008_bib90","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.clon.2010.08.029","article-title":"Brain-sparing holo-cranial radiotherapy: a unique application of helical tomotherapy","volume":"23","author":"Gupta","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clon.2012.02.008_bib91","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0360-3016(00)00494-6","article-title":"Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams","volume":"47","author":"Miralbell","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2012.02.008_bib92","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/COC.0b013e3181841f42","article-title":"Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring: a potential role for parotid-sparing techniques?","volume":"32","author":"Chang","year":"2009","journal-title":"Am J Clin Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655512000696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655512000696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:37:53Z","timestamp":1760542673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655512000696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0936655512000696"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2012.02.008","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy Studies and Extra-nodal Non-Hodgkin Lymphomas, Progress and Challenges","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2012.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}